Ethical Promotion Of Prescription Drugs: IFPMA Code


Published on

Guidelines for interaction between Pharma

1 Comment
  • Good presentation on the ethical pharma promotional guideline, but non of the Tom,Dick and Harry company follow it, I mean to say no PCD Company follow it. They are spoiling the business with malpractices and are promoting irrational combination, which are harmful for the patients and human being.
    Are you sure you want to  Yes  No
    Your message goes here
No Downloads
Total views
On SlideShare
From Embeds
Number of Embeds
Embeds 0
No embeds

No notes for slide

Ethical Promotion Of Prescription Drugs: IFPMA Code

  1. 1. Regulatory guidelines forpromotion of Prescription drugs Based on, IFPMA Code of Pharmaceutical Marketing Practices
  2. 2. Ethical Promotion of prescription Drugs
  3. 3. • It sets out the standards for ethical promotion of pharmaceutical products to healthcare professionals. Implementation of the code is a matter of self regulation and self discipline IFPMA Code of Pharmaceutical Marketing Practices
  4. 4. Does NOT seek to regulate - Promotion of prescription drugs to consumers (DTC advertising). Promotion of self medication products (OTC medications). Provision of non promotional information.
  5. 5. Preamble Industry relationships with healthcareprofessionals must support, and be consistentwith, the professional responsibilities thathealthcare professionals have towards theirpatients. Pharmaceutical companies must maintain highethical standards when conducting promotionalactivities and comply with applicable legal andprofessional
  6. 6. Printed Promotional Material All printed promotional materials other than reminder advertisements must be legible and include :• the name of the product (normally the brand name),• the active ingredients,• the name and address of the pharmaceutical company or its marketing agent,• date of production of the advertisement,• the abbreviated prescribing information.
  7. 7. Abbreviated prescribing informationThis should include the following: Approved Indications Dose Method of use Succinct statement of contraindications, precautions and side effects
  8. 8. Misleading claims Promotional material should not mislead by distortion, exaggeration, undue emphasis or omission, or in any other way. Absolute or all-embracing claims should be used with caution and only with adequate qualification and substantiation. Descriptions such as ‘safe’ and ‘no side effects’ should generally be avoided and should always be adequately qualified.
  9. 9. Substantiation of claims Promotion should be capable of substantiation either by reference to the approved labeling or by scientific evidence. Such evidence should be made available, on request, to healthcare professionals.
  10. 10. Reminder advertisementsIt is a short advertisement consisting of Name Simple statement of indications to designate therapeutic categorySuch reminders may avoid API.
  11. 11. Promotion should not be disguised. Clinical assessments, post-marketing surveillance and experience programs, and post- authorization studies must not be disguised promotion. © D Sharon Pruitt
  12. 12. Transparent sponsorshipsMaterial relating topharmaceuticalproducts and their uses,whether or notpromotional in nature,that is sponsored by acompany, should clearlyindicate by whom it hasbeen sponsored
  13. 13. Medical samples In accordance with local laws and regulations, free samples of a pharmaceutical product may be supplied to healthcare professionals in order to enhance patient care. Samples should not be resold or otherwise misused. Companies should have adequate systems of control and accountability for samples provided to healthcare professionals, including how to look after such samples while they are in the possession of medical representatives
  14. 14. CashPayments in cash or cash equivalents (such as giftcertificate) must not be offered to healthcareprofessionals.Personal giftsGifts for the personal benefit of healthcareprofessionals (including, but not limited to, music CDs,DVDs, sporting or entertainment tickets, electronicitems) must not be provided or offered.Cultural courtesy giftsAn inexpensive gift not related to the practice ofmedicine may be given on an infrequent basis tohealthcare professionals in acknowledgement ofsignificant national, cultural or religious holidays.
  15. 15.  Promotional aids Promotional aids or reminder items may be provided or offered to healthcare professionals and appropriate administrative staff, provided that the gift is of minimal value and relevant to the practice of the healthcare professional.  Medical Utility items Items of medical utility may be offered or provided free of charge, provided that such items are of modest value and beneficial to the provision of medical services and for patient
  16. 16. Electronic MediaIncluding audiovisuals The same requirements that apply to printed materials also apply to electronic promotional materials and websites.
  17. 17. Websites• The identity of the pharmaceutical company and of the intended audience should be readily apparent.• The content should be appropriate for the intended audience.• The presentation (content, links, etc.) should be appropriate and apparent to the intended audience.
  18. 18. SponsorshipLimited to, Travel Meals Accommodation Registration fees
  19. 19. Hospitality  Companies should avoid using renowned or extravagant venues. • Hospitality should be limited to moderate and reasonable refreshments and/or meals incidental to the main purpose of the event and should be provided only to participants in the event and not their guests.
  20. 20.  As a general rule, the hospitality provided should not exceed what healthcare professional recipients would normally be prepared to pay for themselves. • No stand-alone entertainment or other leisure or social activities should be provided or paid for by member companies. At events, entertainment of modest nature, which is secondary to refreshments and/or meals, is
  21. 21. CompensationPayments of reasonable fees and reimbursement may be provided to healthcare professionals who are providing genuine services as speakers or presenters on the basis of a written contract with the company at the event.Other Healthcare professionals cannot be compensated for time spent in attending an event, e.g. a company-sponsored meeting or scientific congress.
  22. 22. IFPMA Code of Pharmaceutical Marketing Practices Blog Youtube Follow me @edrneelesh Facebook